Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Murai

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Medicine|March 14, 2026
Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Retrospective Analysis of 1182 Patients from the Niigata Orthopedic Surgery Rheumatoid Arthritis Database (NOSRAD)Nariaki Hao, Naoki Kondo, Katsumitsu Arai, et al.
Modern Rheumatology|May 26, 2009
Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1 yearHiroshige Sano, Katsumitsu Arai, Takehiro Murai, et al.
Microscopy Research and Technique|September 15, 2006
High dose glucocorticoid hampers bone formation and resorption after bone marrow ablation in ratNaoki Kondo, Kunihiko Tokunaga, Tomoyuki Ito, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2012
Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominisHiroe Sato, Noriaki Iino, Riuko Ohashi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Medicine|March 14, 2026
Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Retrospective Analysis of 1182 Patients from the Niigata Orthopedic Surgery Rheumatoid Arthritis Database (NOSRAD)Nariaki Hao, Naoki Kondo, Katsumitsu Arai, et al.
Modern Rheumatology|May 26, 2009
Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1 yearHiroshige Sano, Katsumitsu Arai, Takehiro Murai, et al.
Microscopy Research and Technique|September 15, 2006
High dose glucocorticoid hampers bone formation and resorption after bone marrow ablation in ratNaoki Kondo, Kunihiko Tokunaga, Tomoyuki Ito, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2012
Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominisHiroe Sato, Noriaki Iino, Riuko Ohashi, et al.
Pageof 2